SEND NEWS ARTICLE TO FRIEND
To Email:
From Email:
News Headline
EUSA Pharma Acquires Development and Commercialization Rights to ASPAREC(R) for Treatment of Acute Lymphoblastic Leukemia from Alizé Pharma